Ligand profile
IDN
Ligand co-crystallized with a similar protein (Protein Data Bank).
Bound to: KP13_05433 — Enoyl-[acyl-carrier-protein] reductase [NADH]
Identifiers
Database identifiers and provenance.
- Ligand ID
IDN- PDB
1mfp- UniProt (similar protein)
P0AEK4- Target protein
- KP13_05433
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 67.2
- −1 ≤ LogP ≤ 5 3.13
- MW ≤ 500 Da 374.4
- LogP ≤ 5 3.13
- H-bond donors ≤ 5 1
- H-bond acceptors ≤ 10 4
- Rotatable bonds ≤ 10 4
- TPSA ≤ 140 Ų 67.2
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
Cn1cc(c2c1cccc2)CN(C)C(=O)\C=C\c3cc4c(nc3)NC(=O)CC4Cn1cc(c2c1cccc2)CN(C)C(=O)\C=C\c3cc4c(nc3)NC(=O)CC4
InChI=1S/C22H22N4O2/c1-25-13-17(18-5-3-4-6-19(18)25)14-26(2)21(28)10-7-15-11-16-8-9-20(27)24-22(16)23-12-15/h3-7,10-13H,8-9,14H2,1-2H3,(H,23,24,27)/b10-7+InChI=1S/C22H22N4O2/c1-25-13-17(18-5-3-4-6-19(18)25)14-26(2)21(28)10-7-15-11-16-8-9-20(27)24-22(16)23-12-15/h3-7,10-13H,8-9,14H2,1-2H3,(H,23,24,27)/b10-7+
VAZMNDXVXVUKFY-JXMROGBWSA-NVAZMNDXVXVUKFY-JXMROGBWSA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ sequence
- Source
- PDB
- Binding sites
- PF13561
External resources
Open this ligand in third-party databases and cheminformatics tools.
- PDB RCSB ligand IDN →
- PDB RCSB structure 1mfp →
- UniProt UniProt P0AEK4 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “IDN”) →
Other ligands for this protein
Quick navigation to other ligands bound to KP13_05433.
PDB 16
Ligands co-crystallized with this protein (structural evidence).
ChEMBL 60
Compounds with measured inhibitory activity on this target (higher pchembl = more potent).
ZINC 50
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).